Extra‐pancreatic action of glibenclamide in man: reduction in vitro of the inhibitory effect of glucagon and epinephrine on the hepatic key glycolytic enzymes phosphofructokinase (PFK) and pyruvate kinase (PK)

European Journal of Clinical Investigation

Volumn 19, Issue 4, 1989, Pages 367-371

  BELFIORE, F ^a   RABUAZZO, AGATA M ^a   IANNELLO, SILVIA ^a   CAMPIONE, ROSA ^a   CASTORINA, S ^b   URZI, F ^b  

^a Istituto di Clinica Medica III ^*

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Epinephrine; glibenclamide; glucagon; gluconeogenesis; human liver; phosphofructokinase; pyruvate kinase

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ADRENALIN; GLIBENCLAMIDE; GLUCAGON; PYRUVATE KINASE;

GLYCOLYSIS; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; ANIMAL; DRUG INTERACTIONS; EPINEPHRINE; FEMALE; GLUCAGON; GLUCONEOGENESIS; GLYBURIDE; GLYCOLYSIS; HUMAN; LIVER; MALE; MICE; MIDDLE AGE; PHOSPHOFRUCTOKINASE-1; PYRUVATE KINASE;

EID: 0024397495     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.1989.tb00243.x     Document Type: Article

References (38)

1. The pharmacology of sulfonylureas
2. Clinical pharmacology of oral antidiabetic agents
3. Pancreatic action of the sulfonylureas
4. Endocrine and metabolic effects of glibenclamide. Evidence for an extrapancreatic mechanism of action
5. Effect of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients
6. Potentiation of insulin action: A probable mechanism for the antidiabetic action of sulfonylurea drugs
7. Increased insulin sensitivity and cellular insulin binding in obese diabetics following treatment with glibenclamide
8. Extrapancreatic action of sulphonylureas: Effect of gliquidone on insulin and glucagon binding to rat liver plasma membranes
9. Direct in vitro effect of a sulfonylurea to increase human fibroblast insulin receptors
10. The acute and chronic effects of sulfonylurea therapy in type 2 diabetic subjects
11. In vitro effects of a sulfonylurea on insulin action in adipocytes
12. Potentiation of insulin action by a sulfonylurea in primary cultures of hepatocytes from normal and diabetic rats
13. Extrapancreatic action of the sulphonylurea gliquidone: Postreceptor effect on insulin‐stimulated glycogen synthesis in rat hepatocytes in primary culture
14. Chlorpropamide stimulates glycolysis and inhibits gluconeogenesis in isolated rat hepatocytes by increasing fructose 2,6‐bisphosphate concentration
15. Tolbutamide stimulates fructose‐2,6‐bisphosphate formation in perfused rat liver
16. Insulin‐like and insulin‐enhancing effects of the sulfonylurea glyburide on rat adipose glycogen synthase
17. Gliclazide therapy is associated with potentiation of postbinding insulin action in obese, non‐insulin‐dependent diabetic subjects
18. Oral sulfonylurea agents suppress hepatic glucose production in non‐insulin‐dependent diabetic individuals
19. Rat liver phosphofructokinase isozymes
20. Hepatic pyruvate kinase
21. Regulation of phosphofructokinase activity by glucagon in isolated rat hepatocytes
22. Hormonal control of pyruvate kinase activity and of gluconeogenesis in isolated hepatocytes
23. Protein measurement with the Folin‐phenol reagent
24. Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs
25. Studies on the kinetic effects of adenosine‐3′:5′‐monophosphate‐dependent phosphorylation of purified pig liver pyruvate kinase type L
26. Regulation in vitro of rat liver pyruvate kinase by phosphorylation‐dephosphorylation reactions, catalyzed by cyclic‐AMP‐dependent protein kinases and a histone phosphatase
27. Regulation by glucagon of hepatic pyruvate kinase, 6‐phosphofructo 1‐kinase and fructose‐1,6‐bisphosphatase
28. Glucagon‐induced phosphorylation of pyruvate kinase (type L) in rat liver slices
29. Hormone‐induced changes in pyruvate kinase activity in isolated hepatocytes. II. Relation to the hormonal regulation of gluconeogenesis
30. Gluconeogenesis in rabbit liver. The effects of glucagon, epinephrine, alpha‐ and beta‐adrenergic agents on gluconeogenesis and pyruvate kinase in hepatocytes given dihydroxyacetone or fructose
31. Rapid reciprocal changes in rat hepatic glycolytic enzyme and fructose‐diphosphatase activities following insulin and glucagon injection
32. Stimulation by glucagon of in vivo phosphorylation of rat hepatic pyruvate kinase
33. Modulation of the phosphorylation state of rat liver pyruvate kinase by allosteric effectors and insulin
34. Control of the fructose 6‐phosphate/fructose 1,6‐bisphosphate cycle in isolated hepatocytes by glucose and glucagon
35. The action of insulin on hepatic fructose 2,6‐bisphosphate metabolism
36. 2 futile cycle during gluconeogenesis in the liver